Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. | Eli Lilly—which has already staged multiple efforts in ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved ...

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

Eli Lilly said copycat versions of Zepbound that add B12 result in potentially dangerous impurities. The compounding industry says there’s not enough information to issue warnings.

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

Pharmaceutical companies in Europe are blocking the sale of drugs used for lethal injection in the U.S. That has states that use the drugs turning to compounding pharmacies to create them. David ...

Please provide your email address to receive an email when new articles are posted on . As of the end of October, 28 deaths resulting from the use of poorly prepared compounded medications by a ...

When approved drugs do not exist for a species, condition or delivery route, compounded medications can fill the gap. These formulations provide new flexibility for managing livestock health.